Pocket Program - CROI

CROI 2013 Session 171
+ 924
Women Who Received
PMTCT
R Masaba1 , C Zeh2 , S Girde3 , C Borkowf4 , R Ndivo1 , I Nyangau1 ,
K Achola1 , T Thomas2 , and Shirley Lee Lecher* 4
1 2 3 Kenya Med Res Inst, Kisumu;; CDC, Kisumu, Kenya;; ICF Intl, Atlanta,
GA, US;; and 4 932
Botswana
R Shapiro
CDC, Atlanta, GA, US
1,2,3 , S Rossi4 , Anthony Ogwu* 3 , M Moss4 , J Leidner1 ,
S Lockman1,3,5 , S Moyo3 , J Makhema1,3 , M Essex1,3 , and E Capparelli4 1 2 Harvard Sch of Publ Hlth, Boston, MA, US;; Beth Israel Deaconess Med
Ctr, Boston, MA, US;; 3Botswana-Harvard Partnership, Gaborone;; 4Univ of California, San Diego, US;; and 5 MA, US
925 Pregnancy Outcomes in HIV + Women with Advanced
Giuseppina Liuzzi* 1 , C Pinnetti 1 , E Tamburrini 2 , M Ravizza 3 ,
A Vigano 4 , A degli Antoni 5 , G Guaraldi 6 , A Maccabruni 7 , M Floridia 8 ,
and Italian Group on Surveillance on ART in Pregnancy
1 Natl Inst for Infectious Diseases Lazzaro Spallanzani, Rome, Italy;;
2 Catholic Univ, Rome, Italy;; 3 S Paolo Hosp, Milan, Italy;; 4 Luigi Sacco
Hosp, Univ of Milan, Italy;; 5 Azienda Ospedaliera di Parma, Italy;; 6 Univ
of Modena and Reggio Emilia, Modena, Italy;; 7 IRCCS S Matteo, Pavia,
Italy;; and 8 Istituto Superiore di Sanita, Rome, Italy
c Tuesday, 2:30-4 pm; Hall B2
Session 167–Poster Abstracts
Breast Feeding and Prevention of Postnatal MTCT
927 Predictors of Early Breastfeeding Cessation among HIV +
Anthony Ogwu* 1,2 , S Moyo 1 , D Kitch 2 , J Leidner 2 , K Powis 1,2 ,
S Lockman 1,2,3 , J Makhema 1,2 , M Pagano 2 , M Essex 1,2 , and R Shapiro 1,2,4
1 Botswana-Harvard AIDS Inst, Gaborone;; 2 Harvard Sch of Publ Hlth,
+ 928
Mothers Administering Longterm
Nevirapine Syrup to Their Infants at Home: Mulago
Joyce Namale Matovu* 1 , Z Namukwaya1 , M Mubiru1 , E Musingye1 ,
M Kyarimpa1 , A Kakande1 , S Kamya1 , P Musoke1 , M Kamya2 ,
and MG Fowler1,3 1Makerere UnivJohns Hopkins Univ Res Collaboration, Kampala,
Uganda;; 2Mulago Mbarara Teaching Hosp Joint AIDS Prgm, Kampala,
Uganda;; and 3Johns Hopkins Med Inst, Baltimore, MD, US
c Tuesday, 2:30-4 pm; Hall B2
Session 168–Poster Abstracts
ARV Pharmacokinetics during Pregnancy and
Breast Feeding
931 A Comparison of the Pharmacokinetics of Maraviroc during
Pregnancy and Postpartum
Angela Colbers* 1 , B Best 2 , J Wang 3 , A Stek 4 , C Hidalgo Tenori 5 ,
D Hawkins 6 , G Taylor 7 , E Capparelli 2 , D Burger 1 , M Mirochnick 8 ,
on behalf of PANNA Network and IMPAACT P1026
1 Radboud Univ Nijmegen Med Ctr, The Netherlands;; 2 Univ of California,
San Diego, US;; 3 Ctr for Biostatistics in AIDS Res, Harvard Sch of Publ
Hlth, Boston, MA, US;; 4 Univ of Southern California Keck Sch of Med, Los
Angeles, US;; 5 Hosp Univ Virgen de las Nieves Granada, Spain;; 6 Chelsea
and Westminster Hosp, London, UK;; 7 Imperial Coll Hlthcare NHS Trust,
London, UK;; and 8 Boston Univ Sch of Med, MA, US
933 Exposure of Breastfed Infants to Maternal Efavirenz from
Breast Milk
Adeniyi Olagunju* 1,2 , A Amara 2 , J Tjia 2 , M Siccardi 2 , J Oyigboja 3 ,
O Bolaji 1 , S Khoo 2 , and A Owen 2
1 Obafemi Awolowo Univ, Ile-Ife, Nigeria;; 2 Univ of Liverpool, UK;;
and 3 Ctr for Clin Res, Nigeria
926 Safety of in Utero and Neonatal ARV Exposure: Effects on
Cognitive and Academic Outcomes in
Molly Nozyce* 1 , Y Huo2 , P Williams2 , S Kapetanovic3 , R Hazra4 ,
S Nichols5 , S Hunter6 , K Rich6 , G Seage2 , P Sirois7 , and Pediatric
HIV/AIDS Cohort Study
1 2 Jacobi Med Ctr, Bronx, NY, US;; Harvard Sch of Publ Hlth, Boston,
MA, US;; 3Natl Inst of Mental Hlth, NIH, Washington, DC, US;; 4Natl Inst
of Child Hlth and Human Devt, NIH, Washington, DC, US;; 5Univ of
California, San Diego, US;; 6Univ of Chicago, IL, US;; and 7 934 Effect of Seven Days Phenytoin on Pharmacokinetics of
and Resistance to Single-dose Nevirapine for Perinatal HIV
Prevention: A Randomized Pilot Study
Catherine Chunda*
Tulane Univ
Sch of Med, New Orleans, LA, US
1 , Q Fillekes2 , E Muro3 , M Thomason4 ,
S Aitken5 , E Kisanga3 , C Kankasa1 , D Gibb4 , S Walker4 , and D Burger2 1 2 Univ Teaching Hosp, Lusaka, Zambia;; Radboud Univ Nijmegen Med
Ctr, The Netherlands;; 3Kilimanjaro Christian Med Coll, Moshi, Tanzania;;
4 5 MRC Clin Trials Unit, London, UK;; and Utrecht Univ Med Ctr, The
Netherlands
c Tuesday, 2:30-4 pm; Hall B2
Session 169–Poster Abstracts
ARV Regimens and Safety during Pregnancy
Program 61
Poster Listings
935
and Peripartum Viral Load of Increased Lopinavir/Ritonavir
Dose in Pregnancy
Simone Bonafe*, J Senise, D Costa, MJ Vaz, A Castelo,
and Nucleo de Patologias Infecciosas da Gestacao
Federal Univ of Sao Paulo, Brazil
Boston, MA, US;; 3 936 Incidence and Management of Adverse Events to Nevirapine
in Pregnancy in a Resource-constrained Setting
4
Beth
Francesca Bisio*
Isreal Deaconess Med Ctr, Boston, MA, US
1 , E Schenone1 , S Grignolo1 , A Calzi1 , M Guaitolini1 ,
DR Giacobbe1 , G Masini1 , I Bitari2 , B Bruzzone3 , and C Viscoli1,3 1 2 Univ of Genoa, Italy;; Army Hosp, Pointe Noire, Republic of Congo;;
and 3IRCSS AOU San Martino-IST, Genoa, Italy
929
for PMTCT: Adherence and Nevirapine Exposure
Jim Aizire* 1 , E Capparelli2 , C Herron3 , E Brown3 , A Desmond4 ,
S Eshleman5 , B Maldonado6 , K Manji7 , MG Fowler5 , M Mirochnick8 ,
and HPTN 046 Study Team
1Makerere Univ-Johns Hopkins Univ Res Collaboration, Kampala,
Uganda;; 2Univ of California, San Diego, US;; 3Fred Hutchinson Cancer
Res Ctr, Seattle, WA, US;; 4CAPRISA, Nelson R Mandela Sch of Med,
Univ of KwaZulu-Natal, Durban, South Africa;; 5Johns Hopkins Univ
Sch of Med, Baltimore, MD, US;; 6Stanford Univ Sch of Med, CA, US;;
7Muhimbili Univ of Hlth and Allied Sci, Dar es Salaam, Tanzania;; and
8Boston Univ Sch of Med, MA, US
930 Role of Intestinal Mucosal Integrity in HIV Transmission
Athena Kourtis* 1 , C Ibegbu2 , J Wiener1 , C King1 , G Tegha3 , D Kamwendo3 ,
V Flax4 , D Kayira3 , C van der Horst4 , D Jamieson1 , and BAN Study Team
1 2 3 CDC, Atlanta, GA, US;; Emory Univ, Atlanta, GA, US;; UNC Project,
Lilongwe, Malawi;; and 4 c Monday, 2:30-4 pm; Hall B2
Session 170–Poster Abstracts
Incidence and Prevention of PMTCT-associated
Drug Resistance
937
in Women Treated with Zidovudine Monotherapy for PMTCT
Scott Olson*
Univ of North Carolina at Chapel Hill, US
1 , N Ngo-Giang-Huong2 , I Beck3 , R Hall1 , R Bumgarner1 ,
W Deng1 , J Mullins1 , R Van Dyke4 , G Jourdain2 , and L Frenkel1,3 1 2 Univ of Washington, Seattle, US;; Inst de Recherche pour le Devt UMI
174-PHPT, Chiang-Mai, Thailand;; 3 and 4Tulane Univ Sch of Med, New Orleans, LA, US
938 Effect of Short-course Maternal ARV Regimens
after Single-dose Nevirapine on HIV-1 Transmission and
Jane Hitti* 1 , E Halvas2 , L Zheng3 , F Taulo4 , J Kabanda5 , H Sprenger6 ,
K Klingman7 , E Chan3 , D McMahon2 , J Mellors2 , and ACTG A5207
Protocol Team
1 2 3 Univ of Washington, Seattle, US;; Univ of Pittsburgh, PA, US;; Harvard
Sch of Publ Hlth, Boston, MA, US;; 4Queen Elizabeth Central Hosp,
Blantyre, Malawi;; 5Joint Clin Res Ctr, Kampala, Uganda;; 6Frontier Sci
Tech and Res Fndn, Amherst, NY, US;; and 7Therapeutics Res Prgm,
DAIDS, NIH, Bethesda, MD, US
c Monday, 2:30-4 pm; Hall B2
Session 171–Poster Abstracts
New HIV Infections among Children in the US
939
Steven Nesheim* 1 , L Linley 1 , S Whitmore 1 , T Kajese 2 , H Shericka 2 ,
L Fitz Harris 2 , M Lampe 1 , and A Taylor 1
1 CDC, Atlanta, GA, US and 2 ICF Intl, Atlanta, GA, US